A phase II trial of ZD0473 in platinum-pretreated ovarian cancer

By Gore M.E.   Atkinson R.J.   Thomas H.   Cure H.   Rischin D.   Beale P.   Bougnoux P.   Dirix L.   Smit W.M.  

European Journal of Cancer, Vol. 38, Iss. 18, 2002-12 ,pp. : 2416-2420

Elsevier

Access to resources Recommend Favorite

Sequence-dependent synergism between the new generation platinum agent ZD0473 and paclitaxel in cisplatin-sensitive and -resistant human ovarian carcinoma cell lines

By Rogers P.   Boxall F.E.   Allott C.P.   Stephens T.C.   Kelland L.R.  

European Journal of Cancer, Vol. 38, Iss. 12, 2002-08 ,pp. : 1653-1660

Elsevier

Access to resources Recommend Favorite

Retention of activity by the new generation platinum agent AMD0473 in four human tumour cell lines possessing acquired resistance to oxaliplatin

By Sharp S.Y.   O'Neill C.F.   Rogers P.   Boxall F.E.   Kelland L.R.  

European Journal of Cancer, Vol. 38, Iss. 17, 2002-11 ,pp. : 2309-2315

Elsevier

Access to resources Recommend Favorite

Effects of a novel trinuclear platinum complex in cisplatin-sensitive and cisplatin-resistant human ovarian cancer cell lines: interference with cell cycle progression and induction of apoptosis

By Orlandi L.   Colella G.   Bearzatto A.   Abolafio G.   Manzotti C.   Daidone M.G.   Zaffaroni N.  

European Journal of Cancer, Vol. 37, Iss. 5, 2001-03 ,pp. : 649-659

Elsevier

Access to resources Recommend Favorite

Resistance to platinum-based chemotherapy in lung cancer cell lines

By Chen Jianli   Emara Nashwa   Solomides Charalambos   Parekh Hemant   Simpkins Henry  

Cancer Chemotherapy and Pharmacology, Vol. 66, Iss. 6, 2010-11 ,pp. : 1103-1111

Springer Publishing Company

Access to resources Recommend Favorite